Affiliation:
1. Amur State Medical Academy
2. Amur Regional Clinical Hospital
Abstract
Aim. Demonstration of three clinical cases of immune thrombocytopenic purpura (ITP) that developed during the pandemic of a novel coronavirus infection (COVID-19) from the personal practice of the authors.Materials and methods. A brief review of the literature on the diagnosis and differential diagnosis of COVID-19-associated ITP is presented. Three clinical observations of this pathology are given.Results. In two situations, thrombocytopenia developed after severe COVID-19-associated pneumonia. In one case, ITP was diagnosed after a viral infection; PCR test for COVID19 was negative. A young patient without comorbidities with severe thrombocytopenia and hemorrhagic syndrome was treated with glucocorticoids and thrombopoietin receptor agonists (TPO-RAs). After achieving remission, glucocorticoids were first discontinued, and then TPO-RAs. In elderly patients with a serious comorbid pathology, glucocorticoids were prescribed for a short time, and remission was achieved with TPO-RAs.Conclusion. The choice of therapy for ITP that developed during the COVID-19 pandemic depends on the clinical situation, the presence or absence of COVID-19 infection, the patient’s somatic status, and the presence of comorbid pathology. TPO-RAs play an important role in the treatment of ITP, including those associated with COVID-19.
Publisher
Far Eastern Scientific Center Of Physiology and Pathology of Respiration
Reference22 articles.
1. Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B., Chong B.H., Cines D.B., Gernsheimer T.B., Godeau B., Grainger J., Greer I., Hunt B.J., Imbach P.A., Lyons G., McMillan R., Rodeghiero F., Sanz M.A., Tarantino M., Watson S., Young J., Kuter D.J. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115(2):168‒186. https://doi.org/10.1182/blood-2009-06-225565
2. Rodeghiero F., Stasi R., Gernsheimer T., Michel M., Provan D., Arnold D.M., Bussel J.B., Cines D.B., Chong B.H., Cooper N., Godeau B., Lechner K., Mazzucconi M.G., McMillan R., Sanz M.A., Imbach P., Blanchette V., Kühne T., Ruggeri M., George J.N. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113(11):2386‒2393. https://doi.org/10.1182/blood-2008-07-162503
3. Mazurov A.V. [Physiology and pathology of platelets]. Moscow: Litterra; 2011 (in Russian). ISBN: 978-5-42350049-8
4. Melikyan A.L., Pustovaya E.I. [Algorithm for the diagnosis of primary immune thrombocytopenia. In: Savchenko V.G., editor. Algorithms for the diagnosis and treatment of diseases of the blood system (Vol.1)]. Moscow: Praktika; 2018:231–242 (in Russian). ISBN: 978-5-89816-164-4
5. Thota S., Kistangari G., Daw H., Spiro T. Immune thrombocytopenia in adults: an update. Cleve. Clin. J. Med. 2012; 79(9):641‒650. https://doi.org/10.3949/ccjm.79a.11027